Phacilitate Leaders World

Sponsors & Exhibitors

Sponsors & Exhibitors

Loading
  • Letter
    • V
  • VGXI Inc

    Stand: 713
    VGXI is a leading contract manufacturer of DNA based pharmaceuticals with over 15 years of experience providing high quality cGMP products to clinical trials worldwide. The company’s production servic ...
  • Vibalogics GmbH

    Stand: 3
    Vibalogics is a Contract Development and Manufacturing Organisation (CDMO) offering process development, cGMP manufacturing and fill/finish of products based on viruses and live bacteria for companies ...
  • Vigene Biosciences

    Stand: 14
    Vigene Biosciences’ mission is to make gene therapy affordable.  On basic research side, Vigene is developing, manufacturing, and distributing state-of-the-art AAV, lentivirus and adenovirus based rea ...
  • Vineti

    Stand: 609
    Vineti combines industry-leading software expertise with deep first-hand, knowledge of commercializing personalized cell therapies to digitize the supply chain, manufacturing and compliance systems fo ...
  • Vivex Biomedical Inc

    Stand: WSC6
    Vivex is a regenerative biomedical company dedicated to creating new standards in patient care. Vivex strives to create treatment options and solutions that will improve clinical, surgical, and therap ...
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK